endothelin-1 has been researched along with Hemorrhoids* in 2 studies
2 other study(ies) available for endothelin-1 and Hemorrhoids
Article | Year |
---|---|
Endothelin-1 and its receptors on haemorrhoidal tissue: a potential site for therapeutic intervention.
Haemorrhoids is a common anorectal condition affecting millions worldwide. We have studied the effect of endothelin-1 (ET-1) and the role of endothelin ET. Protein expression of ET-1, ET. Dense binding of [. ET Topics: Autoradiography; Binding Sites; Blotting, Western; Endothelin-1; Hemorrhoids; Humans; Immunohistochemistry; Receptors, Endothelin | 2017 |
Pharmacological characteristics of endothelin receptors on sheep rectal blood vessels.
Haemorrhoids is associated with high blood flow of the anorectal region. The question of whether pharmacological manipulation of vascular supply can relieve the symptoms of haemorrhoids has been raised. In order to undertake this type of clinical investigation, it is first essential to gain a better understanding of the properties of vascular receptors that may regulate blood flow into anal cushions and haemorrhoids. Due to the limited availability of human anorectal specimens and the good reliability of sheep tissue as an experimental model of human anorectal diseases, we studied the properties of endothelin receptors in sheep rectal artery (SRA) and vein (SRV), the vessels contributing to the blood flow of haemorrhoidal plexus, using isometric tension recordings. We found that endothelin-1 and sarafotoxin 6a were very potent constrictor agents in both SRA and SRV. The selective ET(A) receptor antagonist PD156707 (100 nM) produced a parallel rightward displacement of ET-1-induced contractions in both vessels and abolished sarafotoxin 6a-induced contractions in the SRA. PD156707 (3 μM) practically abolished contractions to ET-1 in the SRA, suggesting that the response is entirely mediated by ET(A) receptors. While, the selective ET(B) receptor antagonist BQ788 (100 nM) caused no significant change in ET-1-induced contractions in both vessels, a minor role for ET(B) receptor subtype to responses to sarafotoxin 6a in the artery was suggested. Topics: Animals; Antihypertensive Agents; Blood Vessels; Dioxoles; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Hemorrhoids; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Oligopeptides; Piperidines; Potassium Chloride; Receptors, Endothelin; Rectum; Sheep; Vasoconstriction; Vasoconstrictor Agents; Viper Venoms | 2011 |